Loading…
AgomAb Therapeutics NV
AgomAb Therapeutics NV (AGMB) is listed on NASDAQ and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Antwerp, Belgium and has 62 employees. The company is worth $407.77M. Revenue was €0 in fiscal 2025. It reported a net loss of €62.55M. The share price is 53.5% below its 52-week high of $17.82. One of the 38 superinvestors we track held it at the end of Q2 2026: Two Sigma (Two Sigma Investments), at $234.58K. Over the last 30 days, company insiders bought $267.67K of its stock on the open market and sold none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Revenue, debt and profit are in EUR, the currency the company reports in — not converted to dollars. Dividends are in dollars.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| DMACDiaMedica Therapeutics Inc. | $7.57 | — | 10.6x | 0.00% | -114.61% | $408.22M |
| CYHCommunity Health Systems Inc | $2.91 | 1.6x | — | 0.00% | — | $410.34M |
| SENSSenseonics Holdings, Inc. | $7.77 | — | 4.5x | 0.00% | -118.24% | $410.83M |
| OFIXOrthofix Medical Inc. | $9.99 |
| — |
| 0.9x |
| 0.00% |
| -13.91% |
| $403.81M |
| TECXTectonic Therapeutic, Inc. | $20.65 | — | 1.8x | 0.00% | -33.80% | $403.69M |
| RCELAVITA Medical, Inc. | $13.04 | — | — | 0.00% | — | $403.29M |